TransDigm Group Balance Sheet Health
Financial Health criteria checks 0/6
TransDigm Group has a total shareholder equity of $-6.3B and total debt of $24.6B, which brings its debt-to-equity ratio to -391.9%. Its total assets and total liabilities are $25.6B and $31.9B respectively. TransDigm Group's EBIT is $3.6B making its interest coverage ratio 2.8. It has cash and short-term investments of $6.3B.
Key information
-391.9%
Debt to equity ratio
US$24.63b
Debt
| Interest coverage ratio | 2.8x |
| Cash | US$6.32b |
| Equity | -US$6.28b |
| Total liabilities | US$31.87b |
| Total assets | US$25.59b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: T7D has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: T7D has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: T7D has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: T7D's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: T7D's debt is not well covered by operating cash flow (8.3%).
Interest Coverage: T7D's interest payments on its debt are not well covered by EBIT (2.8x coverage).